Survey of vaccine distribution and delivery issues in the USA: From pediatrics to pandemics

Expert Review of Vaccines

Volumn 6, Issue 6, 2007, Pages 981-990

  Jacobson, Sheldon H ^a   Sewell, Edward C ^b   Jokela, Janet A ^c  

^a University of Illinois at Urbana Champaign   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Pandemic response; Routine immunization; Vaccine delivery; Vaccine distribution; Vaccine economics; Vaccine supply chain

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; PEDIARIX; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

DIPHTHERIA; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; INFLUENZA; PANDEMIC; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; TETANUS; UNITED STATES; WORLD HEALTH ORGANIZATION;

ANIMALS; DATA COLLECTION; DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS IMMUNIZATION; PEDIATRICS; UNITED STATES;

EID: 37149053451     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.6.6.981     Document Type: Review

References (57)

1. Plotkin SA, Orenstein WA. Vaccines (4th Edition). Elsevier Inc., PA, USA (2004).
2. Diekema DS. Responding to parental refusals of immunization of children. Pediatrics 115(5), 1428-1431 (2005).
3. Mackay IR, Rosen FS. Advances in immunology: vaccines and vaccination. N. Engl. J. Med. 345(14), 1042-1053 (2001).
4. Cohen ML. Changing patterns in infectious disease. Nature 406, 762-767 (2000).
5. Cochi SL. National Immunization Survey. Presented at: The National Press Club. DC, USA 27 July 2005.
6. Binder S, Levitt AM, Sacks JJ, Hughes JM. Emerging infectious diseases: public health issues for the 21st Century. Science 284(5418), 1311-1313 (1999).
7. Centers for Disease Control and Prevention (CDC). Recommended childhood and adolescent immunization schedule - United States. MMWR Morb. Mortal. Wkly Rep. 55(51), Q1-Q4 (2007).
8. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule - United States, October 2006 - September 2007. MMWR Morb. Mortal. Wkly Rep. 55(40), Q1-Q4 (2007).
9. Weniger BG. Economic analysis to meet the challenges of new combination vaccines. Presented at: Vaccine Economics: Planning a Research Agenda for the Challenge of New and Improved Vaccines. Atlanta, GA, USA, 18 December 1996.
10. Centers for Disease Control and Prevention (CDC). Vaccination coverage among children entering school - United States, 2005-2006 school year. MMWR Morb. Mortal. Wkly Rep. 55(41), 1124-1126 (2006).
11. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 55(RR15), 1-48 (2006).
12. Centers for Disease Control and Prevention (CDC). Combination vaccines for childhood immunization. MMWR Morb. Mortal. Wkly Rep. 48(18), RR-5 (1999).
13. Edwards KM, Decker MD. Combination vaccines. Infect. Dis. Clin. North Am. 15(1), 209-230 (2001).
14. Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs B. Challenges and controversies in immunization safety. Infect. Dis. Clin. North Am. 15(1), 21-39 (2001).
15. Flanagan-Klygis EA, Sharp L, Frader JE. Dismissing the family who refuses vaccines: a study of pediatrician attitudes. Arch. Pediatr. Adolesc. Med. 159(10), 929-934 (2005).
16. Jacobson SH, Sewell EC, Proano RA. An analysis of the pediatric vaccine shortage problem. Health Care Manag. Sci. 9(4), 371-389 (2006).
17. Sloan FA, Berman S, Rosenbaum S, Chalk RA, Giffin RB. The fragility of the U.S. vaccine supply. N. Engl. J. Med. 351(23), 2443-2447 (2004). • Provides an overview of the reasons why there are weaknesses in the vaccine supply in the USA, and what can be done to strengthen the associated infrastructure.
18. National Vaccine Advisory Committee (NVAC). Strengthening the supply of routinely recommended vaccines in the United States. JAMA 290(1), 3122-3128 (2003).
19. Jacobson SH, Karnani T, Sewell EC. Analyzing the economic value of the hepatitis B - Haemophilus influenzae type b combination vaccine by reverse engineering a formulary selection algorithm. Vaccine 21(17-18), 2169-2177 (2003).
20. Jacobson SH, Sewell EC, Allwine DA, Medina EA, Weniger BG. Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithms. Expert Rev. Vaccines 2(1), 15-19 (2003).
21. Jacobson SH, Sewell EC, Karnani T. Engineering the economic value of two pediatric combination vaccines. Health Care Manag. Sci. 8(1), 29-40 (2005).
22. Parker FR. FDA Administrative Enforcement Manual. CRC Press, Taylor and Francis Group, FL, USA (2005).
23. US General Accounting Office (USGAO). Report to Congressional Requestors: Childhood Vaccines. Ensuring an Adequate Supply Poses Continuing Challenges. GAO-02-987 (2002).
24. Lane KS, Chu SY, Santoli JM. The United States pediatric vaccine stockpile program. Clin. Infect. Dis. 42(S3), S125-S129 (2006). • Provides a history of, and recent advances with, the US pediatric vaccine stockpile program.
25. Centers for Disease Control and Prevention (CDC). Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb. Mortal. Wkly Rep. 53(8), 177-178 (2004).
26. Centers for Disease Control and Prevention (CDC). Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb. Mortal. Wkly Rep. 53(36), 851-852 (2004).
27. Security and Exchange Commission (SEC). Releases 33-8642, 34-52885, and IC-27178. Commission Guidance Regarding Accounting for Sales of Vaccines and Bioterror Counter-measures to the Federal Government for Placement into the Pediatric Vaccine Stockpile or the Strategic National Stockpile. USA (2005).
28. Traynor K. Vaccine shortages persist despite lessons from past. Am. J. Health Syst. Pharm. 61(23), 2458-2462 (2004).
29. Klein JO, Myers MG, Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions. Clin. Infect. Dis. 42(S3), S97-S103 (2006). • Provides insights into how the US vaccine infrastructure can be strengthened.
30. Manning A. SEC 'glitch' hampers child vaccine. USA Today 12D (2004).
31. Jacobson SH, Sewell EC, Proano RA, Jokela JA. Stockpile levels for pediatric vaccines: how much is enough? Vaccine 24(17), 3530-3537 (2006).
32. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 21(16), 1776-1779 (2002).
33. Corbett CJ, Deo S. Cournot competition under yield uncertainty: the case of the U.S. influenza vaccine market. Technical Report. Anderson School of Management, UCLA, CA, USA (2007).
34. Chick SE, Mamani H, Simchi-Levi D. "Supply chain coordination and influenza vaccination." Technical Report. INSEAD, Fontainebleau, France (2007).
35. Kalvaitis K. Pneumonia now number 1 killer in children. Infect. Dis. News 20(1), 36 (2007).
36. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348(18), 1737-1746 (2003).
37. Fiore AE, Shay DK, Haber P et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Morb. Mortal. Wkly Rep. 56(RR06), 1-54 (2007).
38. Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin. Infect. Dis. 44, 1532-1535 (2007).
39. Larson RC. Simple models of influenza progression within a heterogeneous population. Oper. Res. 53(3), 399-412 (2007).
40. Aaby K, Hermann JW, Jordan CS, Treadwell M, Wood K. Montgomery county's public health service uses operations research. Interfaces 36(6), 569-579 (2006).
41. Aaby K, Abbey RL, Hermann JW, Treadwell M, Jordan CS, Wood K. Embracing computer modeling to address pandemic influenza in the 21st Century. J. Public Health Manag. Pract. 12(4), 365-372 (2006). • Provides a computer simulation model to assess the impact of pandemic influenza on the healthcare infrastructure.
42. Miller G, Randolph S, Patterson JE. Responding to bioterrorist smallpox in San Antonio. Interfaces 36(6) 580-590 (2006).
43. Kaplan E, Craft D, Wein L. Emergency response to a smallpox attack: the case for mass vaccination. Proc. Natl Acad. Sci. USA 99(16), 10935-10940 (2002).
44. Zhang XZ, Meltzer MI, Wortley PM. FluSurge - a tool to estimate demand for hospital services during the next pandemic influenza. Med. Decis. Making 26(6), 617-623 (2006). • Provides a tool to assess surge capacity in hospitals in the event of pandemic influenza.
45. Hanfling D. Equipment, supplies, and pharmaceuticals: how much might it cost to achieve basic surge capacity? Acad. Emerg. Med. 13(11), 1232-1237 (2006). • Provides an analysis to determine the costs of ancillary medical supplies and pharmaceuticals associated with planning for surge capacities.
46. World Health Organization (WHO). Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Sixtieth World Health Assembly. Agenda Item 12.1, WHA60.28, Geneva, Switzerland 23 May 2007.
47. Kieny MP, Costa A, Hombach J et al. A global pandemic influenza vaccine action plan. Vaccine 24(40-41), 6367-6370 (2006).
48. Health and Humans Services (HHS). Request for Information (RFI): guidance for prioritization of pre-pandemic and pandemic influenza vaccine. Fed. Regist. 71(240), 75252-75253 (2006).
49. Maloney L. Are we prepared? Am. J. Health Syst. Pharm. 64(2), 146 (2007).
50. Markel H, Lipman HB, Navarro JA et al. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA 298, 644-654 (2007). • Studies the impact of nonpharmaceutical interventions during the 1918-1919 influenza pandemic.
51. Hatchett RJ, Mecher CE, Lipsitch M. Public health intervention and epidemic intensity during the 1918 influenza pandemic. Proc. Natl Acad. Sci. USA 104(18), 7582-7587 (2007).
52. Grais RF, Ellis JH, Kress A, Glass GE. Modeling the spread of annual influenza epidemics in the U.S.: the potential role of air travel. Health Care Manag. Sci. 7(2), 127-134 (2004).
53. Infectious Disease News (IDN). Global strategy aims for effective malaria vaccine by 2025. Infect. Dis. News 20(1), 45 (2007).
54. Pigliacelli LA. H9N2 adjuvant avian flu vaccine shows strong response. Infect. Dis. News 20(1), 26 (2007).
55. Trust for America's Health. Pandemic flu and the potential for U.S. economic recession: a state-by-state analysis. Issue Report. March (2007).
56. A Surveillance Community Network for Vaccine Preventable Infectious Disease - National Childhood Vaccination Schedules www.euvac.net/graphics/euvac/ vaccination/vaccination.html
57. CDC website www.cdc.gov